Hypertension research

Many patients with high blood pressure try to follow a healthy diet, exercise, and take medications — yet their blood pressure is still high.  

A/Prof Walton is coordinating the SPYRAL Hypertension study, a multi-centre, international, randomised, interventional study, using renal denervation.  The purpose of the Trial is to provide information about the safety and efficacy of the investigational Symplicity Spyral™ catheter and the Symplicity G3™ generator to help reduce blood pressure.   To be eligible for the Trial, patients must be between the ages of 20 and 80 and have uncontrolled hypertension, with readings of 150-180/90mmHg.

Current publications

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

View the publication at The Lancet
Prof Antony Walton

Professor Tony Walton is Deputy Director and Head of Catheter Laboratory in the Department of Cardiology.

Find out more
A/Prof Ingrid Hopper

Associate Professor Ingrid Hopper is a consultant physician at Alfred Health.

Find out more
Prof Murray Esler
News & articles
from Alfred Health
Read latest news